SK282695B6 - Použitie metoklopramidu - Google Patents

Použitie metoklopramidu Download PDF

Info

Publication number
SK282695B6
SK282695B6 SK1259-98A SK125998A SK282695B6 SK 282695 B6 SK282695 B6 SK 282695B6 SK 125998 A SK125998 A SK 125998A SK 282695 B6 SK282695 B6 SK 282695B6
Authority
SK
Slovakia
Prior art keywords
day
metoclopramide
vomiting
effective amount
nasal spray
Prior art date
Application number
SK1259-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK125998A3 (en
Inventor
Mary Psilogenis
Original Assignee
Ribogene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene, Inc. filed Critical Ribogene, Inc.
Publication of SK125998A3 publication Critical patent/SK125998A3/sk
Publication of SK282695B6 publication Critical patent/SK282695B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1259-98A 1996-03-14 1997-03-13 Použitie metoklopramidu SK282695B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,121 US5760086A (en) 1996-03-14 1996-03-14 Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en) 1996-03-14 1997-03-13 Nasal administration of agents for treatment of delayed onset emesis

Publications (2)

Publication Number Publication Date
SK125998A3 SK125998A3 (en) 1999-03-12
SK282695B6 true SK282695B6 (sk) 2002-11-06

Family

ID=24468120

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1259-98A SK282695B6 (sk) 1996-03-14 1997-03-13 Použitie metoklopramidu

Country Status (24)

Country Link
US (1) US5760086A (de)
EP (1) EP0891186B1 (de)
JP (1) JP2000507234A (de)
KR (1) KR100420673B1 (de)
CN (1) CN1217657A (de)
AT (1) ATE489137T1 (de)
AU (1) AU707467B2 (de)
BG (1) BG102780A (de)
CA (1) CA2248968C (de)
CZ (1) CZ289797B6 (de)
DE (1) DE69740060D1 (de)
DK (1) DK0891186T3 (de)
EE (1) EE03665B1 (de)
ES (1) ES2357520T3 (de)
IL (1) IL126199A (de)
NO (1) NO984245L (de)
NZ (1) NZ331991A (de)
PL (1) PL328940A1 (de)
PT (1) PT891186E (de)
RU (1) RU2181588C2 (de)
SK (1) SK282695B6 (de)
UA (1) UA57733C2 (de)
WO (1) WO1997033573A1 (de)
YU (1) YU40398A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
PL2343987T3 (pl) * 2008-11-11 2013-05-31 Unilever Nv Herbaciana kompozycja
PL2376075T3 (pl) * 2008-12-22 2015-08-31 Evoke Pharma Inc Donosowe preparaty z metoklopramidu
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US20110165143A1 (en) * 2010-01-06 2011-07-07 The Regents Of The University Of Colorado, A Body Corporate Modulation of caspases and therapeutical applications
CN103957707A (zh) 2011-08-25 2014-07-30 伊沃克制药公司 与女性胃轻瘫有关的症状的治疗
FR2980976B1 (fr) * 2011-10-10 2015-10-16 Mohamed Skiba Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) * 2015-01-06 2015-05-13 中国人民解放军军事医学科学院毒物药物研究所 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
US11517545B2 (en) 2016-12-15 2022-12-06 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
BG102780A (en) 2000-01-31
UA57733C2 (uk) 2003-07-15
EE9800295A (et) 1999-02-15
NO984245D0 (no) 1998-09-14
PT891186E (pt) 2011-02-25
CZ289797B6 (cs) 2002-04-17
SK125998A3 (en) 1999-03-12
US5760086A (en) 1998-06-02
AU707467B2 (en) 1999-07-08
NO984245L (no) 1998-11-11
WO1997033573A1 (en) 1997-09-18
IL126199A (en) 2004-06-01
DE69740060D1 (de) 2011-01-05
KR100420673B1 (ko) 2004-07-23
NZ331991A (en) 2000-04-28
EP0891186A1 (de) 1999-01-20
EP0891186A4 (de) 2004-03-31
PL328940A1 (en) 1999-03-01
CA2248968C (en) 2005-08-02
IL126199A0 (en) 1999-05-09
RU2181588C2 (ru) 2002-04-27
CN1217657A (zh) 1999-05-26
JP2000507234A (ja) 2000-06-13
ATE489137T1 (de) 2010-12-15
CZ292298A3 (cs) 1999-03-17
KR19990087763A (ko) 1999-12-27
EP0891186B1 (de) 2010-11-24
ES2357520T3 (es) 2011-04-27
AU2210297A (en) 1997-10-01
DK0891186T3 (da) 2011-03-14
CA2248968A1 (en) 1997-09-18
EE03665B1 (et) 2002-04-15
YU40398A (sh) 2001-07-10

Similar Documents

Publication Publication Date Title
US6372790B1 (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
CZ187097A3 (cs) Farmaceutický prostředek
DE60009697T2 (de) Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie
US9107925B2 (en) Sodium channel blocker for treatment of loss of superficial sensitivity
US6537970B1 (en) Pharmaceutical composition
SK282695B6 (sk) Použitie metoklopramidu
DE69801661T2 (de) Zusammensetzungen welche ein ace-hemmer und ein aldosereductasehemmer enthalten
US20040087644A1 (en) Pharmaceutical composition in capsules that comprises a non-steroidal antiinflamatory and an optiate analgesic for handling pain
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
US20080145422A1 (en) Galantamine tablet formulation
IL35341A (en) Antibiotic synergistic compositions containing primycin and another antibiotic and their preparation
Kauffman et al. Anaphylaxis upon switching lipid-containing amphotericin B formulations
SK1272003A3 (en) Medicaments containing cilansetron for treating non-obstipated male IBS patients
US4522827A (en) Method of treating acute pancreatitis with isometheptene
DE10359790A1 (de) Brausezubereitung einer basischen arzneilich wirksamen Substanz
BG63103B1 (bg) Използуване на алендронат за профилактика на остеопороза
US20060079513A1 (en) Methods and compositions including methscopolamine nitrate
US6693100B1 (en) Pharmaceutical compositions for treating psoriasis
MXPA98007474A (en) Nasal administration of agents for the treatment of retard attack emesis
US20060079514A1 (en) Methods and compositions including methscopolamine bromide
US4716177A (en) Tolrestat for inhibition of weight gain
EP0488041A2 (de) Pharmazeutische Zusammensetzung gegen Cytomegalovirusinfektion
DE10123447A1 (de) Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten
Wiseman Ebastine provides new option for treating allergies
WO2002043727A1 (en) Treatment of psychiatric disorders with trimethyl-bicyclo[2.2.1]heptane derivatives